News
Vancouver, British Columbia--(Newsfile Corp. - April 9, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) ("NervGen" or the "Company"), a clinical-stage ...
Vancouver, British Columbia--(Newsfile Corp. - April 9, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) ("NervGen" or the "Company"), a clinical-stage ...
PharmaLogic states that the acquisition of Agilera Pharma AS will place the company in a unique global role in radiopharmaceutical production and distribution. PharmaLogic Holdings Corp., a contract ...
China Pharma (CPHI) Holdings reported that it expects to implement a 1-for-10 reverse stock split on its common stock effective Tuesday, April 15, with trading to begin on a split-adjusted basis ...
Royalty Pharma (RPRX) announced the appointment of Vlad Coric to the company’s board of directors, effective immediately. Vlad Coric is the chairman and CEO of Biohaven (BHVN). Published first ...
Given the extent of India’s pharma exports to US, this has created a certain bit of uncertainty in the market. Trump said the US would impose tariffs on autos, pharmaceuticals and aluminum in ...
If implemented, the looming Trump administration tariffs could hit the sectors hard. There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and ...
The Corporate Sustainability Due Diligence Directive (CSDDD) has been applied in both EU and non-EU pharma companies to promote ethical business practices. This policy was established to foster ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The company's step-down wholly owned subsidiary, Nauyaan Tradings (NTPL), has completed the acquisition of a 74% equity stake in Nauyaan Shipyard (NSPL) for Rs 382.73 crore from Welspun Corp ...
Purdue Pharma submitted a new bankruptcy plan Tuesday, which will give its creditors more than $7.4 billion in cash—including up to $7 billion in payments from the billionaire Sackler family ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results